Working…
COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC: https://www.coronavirus.gov.

Get the latest research information from NIH: https://www.nih.gov/coronavirus.
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT03653507
Brief Title: A Study of Zolbetuximab (IMAB362) Plus CAPOX Compared With Placebo Plus CAPOX as First-line Treatment of Subjects With Claudin (CLDN) 18.2-Positive, HER2-Negative, Locally Advanced Unresectable or Metastatic Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma (GLOW)

First Submitted : August 24, 2018
First Submitted that Met QC Criteria : August 29, 2018
First Posted : August 31, 2018

Last Update Submitted that Met QC Criteria : September 30, 2020
Last Update Posted : October 5, 2020